A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
-
Published:2018-06-18
Issue:7
Volume:50
Page:979-989
-
ISSN:1061-4036
-
Container-title:Nature Genetics
-
language:en
-
Short-container-title:Nat Genet
Author:
Alvarez Mariano J., Subramaniam Prem S., Tang Laura H., Grunn Adina, Aburi Mahalaxmi, Rieckhof Gabrielle, Komissarova Elena V.ORCID, Hagan Elizabeth A., Bodei Lisa, Clemons Paul A., Dela Cruz Filemon S., Dhall Deepti, Diolaiti Daniel, Fraker Douglas A., Ghavami AfshinORCID, Kaemmerer Daniel, Karan Charles, Kidd Mark, Kim Kyoung M., Kim Hee C.ORCID, Kunju Lakshmi P., Langel Ülo, Li Zhong, Lee JeeyunORCID, Li Hai, LiVolsi Virginia, Pfragner Roswitha, Rainey Allison R., Realubit Ronald B., Remotti Helen, Regberg Jakob, Roses Robert, Rustgi Anil, Sepulveda Antonia R., Serra Stefano, Shi Chanjuan, Yuan Xiaopu, Barberis Massimo, Bergamaschi Roberto, Chinnaiyan Arul M.ORCID, Detre Tony, Ezzat Shereen, Frilling Andrea, Hommann Merten, Jaeger Dirk, Kim Michelle K., Knudsen Beatrice S., Kung Andrew L., Leahy Emer, Metz David C., Milsom Jeffrey W., Park Young S., Reidy-Lagunes Diane, Schreiber Stuart, Washington Kay, Wiedenmann Bertram, Modlin Irvin, Califano Andrea
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Weinstein, I. B. Addiction to oncogenes–the Achilles heal of cancer. Science 297, 63–64 (2002). 2. Tannock, I. F. & Hickman, J. A. Limits to personalized cancer medicine. N. Engl. J. Med. 375, 1289–1294 (2016). 3. Commo, F. et al. Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology. Ann. Oncol. 26, 582–588 (2015). 4. MacConaill, L. E. et al. Prospective enterprise-level molecular genotyping of a cohort of cancer patients. J. Mol. Diagn. 16, 660–672 (2014). 5. Jang, S. & Atkins, M. Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol. 14, e60–e69 (2013).
Cited by
173 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|